OBJECTIVES: Older adults with dementia experience progressive functional decline, which contributes to caregiver burden and nursing home placement. The goal of this systematic review was to determine if any non-pharmacologic interventions have delayed functional decline among community-dwelling dementia patients. METHOD: We completed a systematic literature review to identify controlled clinical trials reporting the impact of non-pharmacologic interventions on any measure of functional impairment or disability among community-dwelling dementia patients. We included studies that reported any proxy-respondent, self-reported, or performance-based standardized assessments. RESULTS: We identified 18 published clinical trials that met inclusion criteria and found that study interventions fell into three different groups: occupational therapy, exercise, and multi-faceted ("other") interventions. The three groups of studies tended to vary systematically regarding the conceptual framework for the disabling process, target of intervention, and type of outcome measure. Approximately half the studies were conducted in the United States with mean sample size of 99 (from 27 to 1131) and follow-up periods between three months and two years. Instruments used to measure functional impairment or disability varied widely with 55 instruments across 18 studies. Nine studies reported a statistically significant improvement in functional decline in the intervention group. CONCLUSION: The current literature provides clinical trial evidence that non-pharmacologic interventions can delay progression of functional impairment or disability among community-dwelling dementia patients. The clinical significance of this early evidence is uncertain. These early studies provide rationale for larger and longer-term studies to determine if these interventions are sufficiently potent to delay institutionalization.
OBJECTIVES: Older adults with dementia experience progressive functional decline, which contributes to caregiver burden and nursing home placement. The goal of this systematic review was to determine if any non-pharmacologic interventions have delayed functional decline among community-dwellingdementiapatients. METHOD: We completed a systematic literature review to identify controlled clinical trials reporting the impact of non-pharmacologic interventions on any measure of functional impairment or disability among community-dwellingdementiapatients. We included studies that reported any proxy-respondent, self-reported, or performance-based standardized assessments. RESULTS: We identified 18 published clinical trials that met inclusion criteria and found that study interventions fell into three different groups: occupational therapy, exercise, and multi-faceted ("other") interventions. The three groups of studies tended to vary systematically regarding the conceptual framework for the disabling process, target of intervention, and type of outcome measure. Approximately half the studies were conducted in the United States with mean sample size of 99 (from 27 to 1131) and follow-up periods between three months and two years. Instruments used to measure functional impairment or disability varied widely with 55 instruments across 18 studies. Nine studies reported a statistically significant improvement in functional decline in the intervention group. CONCLUSION: The current literature provides clinical trial evidence that non-pharmacologic interventions can delay progression of functional impairment or disability among community-dwellingdementiapatients. The clinical significance of this early evidence is uncertain. These early studies provide rationale for larger and longer-term studies to determine if these interventions are sufficiently potent to delay institutionalization.
Authors: Christopher M Callahan; Malaz A Boustani; Frederick W Unverzagt; Mary G Austrom; Teresa M Damush; Anthony J Perkins; Bridget A Fultz; Siu L Hui; Steven R Counsell; Hugh C Hendrie Journal: JAMA Date: 2006-05-10 Impact factor: 56.272
Authors: Lon S Schneider; Pierre N Tariot; Karen S Dagerman; Sonia M Davis; John K Hsiao; M Saleem Ismail; Barry D Lebowitz; Constantine G Lyketsos; J Michael Ryan; T Scott Stroup; David L Sultzer; Daniel Weintraub; Jeffrey A Lieberman Journal: N Engl J Med Date: 2006-10-12 Impact factor: 91.245
Authors: Kristin Martin-Cook; Barbara A Davis; Linda S Hynan; Myron F Weiner Journal: Am J Alzheimers Dis Other Demen Date: 2005 Jul-Aug Impact factor: 2.035
Authors: J Olazarán; R Muñiz; B Reisberg; J Peña-Casanova; T del Ser; A J Cruz-Jentoft; P Serrano; E Navarro; M L García de la Rocha; A Frank; M Galiano; Y Fernández-Bullido; J A Serra; M T González-Salvador; C Sevilla Journal: Neurology Date: 2004-12-28 Impact factor: 9.910
Authors: Quincy M Samus; Betty Smith Black; Diane Bovenkamp; Michael Buckley; Christopher Callahan; Karen Davis; Laura N Gitlin; Nancy Hodgson; Deirdre Johnston; Helen C Kales; Michele Karel; John Jay Kenney; Shari M Ling; Maï Panchal; Melissa Reuland; Amber Willink; Constantine G Lyketsos Journal: Alzheimers Dement Date: 2017-11-21 Impact factor: 21.566
Authors: Eric Jutkowitz; Karen M Kuntz; Bryan Dowd; Joseph E Gaugler; Richard F MacLehose; Robert L Kane Journal: Alzheimers Dement Date: 2017-02-01 Impact factor: 21.566
Authors: Brittany L Bernard; Lauren E Bracey; Kathleen A Lane; Denisha Y Ferguson; Michael A LaMantia; Sujuan Gao; Douglas K Miller; Christopher M Callahan Journal: Alzheimer Dis Assoc Disord Date: 2016 Apr-Jun Impact factor: 2.703
Authors: Arlene A Schmid; Carrie Spangler-Morris; Rachel C Beauchamp; Miranda C Wellington; Whitney M Hayden; Hannah S Porterfield; Denisha Ferguson; Christopher M Callahan Journal: Occup Ther Ment Health Date: 2015-02-11